# Walmart Inc.: financial statements, quarterly

WMT · Nasdaq · CIK 104169 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/wmt.md) · [Financials](/companies/wmt/financials.md) · [Filings](/companies/wmt/filings.md) · [Insiders](/companies/wmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [159](/filings/0000104169-24-000178.md) | [172 d](/filings/0000104169-26-000055.md) | [160](/filings/0000104169-25-000090.md) | [168](/filings/0000104169-25-000137.md) | [168](/filings/0000104169-25-000191.md) | [179 d](/filings/0000104169-26-000055.md) | [164](/filings/0000104169-26-000102.md) | [176](/filings/0000104169-26-000154.md) | [178](/filings/0000104169-25-000191.md) | [189 d](/filings/0000104169-26-000055.md) | [176](/filings/0000104169-26-000102.md) | [186](/filings/0000104169-26-000154.md) |
| Cost of revenue | $bn | [121](/filings/0000104169-24-000178.md) | [132 d](/filings/0000104169-26-000055.md) | [121](/filings/0000104169-25-000090.md) | [127](/filings/0000104169-25-000137.md) | [127](/filings/0000104169-25-000191.md) | [136 d](/filings/0000104169-26-000055.md) | [124](/filings/0000104169-26-000102.md) | [133](/filings/0000104169-26-000154.md) | [135](/filings/0000104169-25-000191.md) | [144 d](/filings/0000104169-26-000055.md) | [133](/filings/0000104169-26-000102.md) | [139](/filings/0000104169-26-000154.md) |
| Selling, general and administrative | $bn | [33.4](/filings/0000104169-24-000178.md) | [34.3 d](/filings/0000104169-26-000055.md) | [33.2](/filings/0000104169-25-000090.md) | [34.6](/filings/0000104169-25-000137.md) | [35.5](/filings/0000104169-25-000191.md) | [36.5 d](/filings/0000104169-26-000055.md) | [34.2](/filings/0000104169-26-000102.md) | [37.3](/filings/0000104169-26-000154.md) | [38.1](/filings/0000104169-25-000191.md) | [38.3 d](/filings/0000104169-26-000055.md) | [37.2](/filings/0000104169-26-000102.md) | [39.8](/filings/0000104169-26-000154.md) |
| Operating income | $bn | [6.2](/filings/0000104169-24-000178.md) | [7.3 d](/filings/0000104169-26-000055.md) | [6.8](/filings/0000104169-25-000090.md) | [7.9](/filings/0000104169-25-000137.md) | [6.7](/filings/0000104169-25-000191.md) | [7.9 d](/filings/0000104169-26-000055.md) | [7.1](/filings/0000104169-26-000102.md) | [7.3](/filings/0000104169-26-000154.md) | [6.7](/filings/0000104169-25-000191.md) | [8.7 d](/filings/0000104169-26-000055.md) | [7.5](/filings/0000104169-26-000102.md) | [9.4](/filings/0000104169-26-000154.md) |
| Income tax | $bn | [0.3](/filings/0000104169-24-000178.md) | [1.8 d](/filings/0000104169-26-000055.md) | [1.7](/filings/0000104169-25-000090.md) | [1.5](/filings/0000104169-25-000137.md) | [1.4](/filings/0000104169-25-000191.md) | [1.5 d](/filings/0000104169-26-000055.md) | [1.4](/filings/0000104169-26-000102.md) | [2.2](/filings/0000104169-26-000154.md) | [2.1](/filings/0000104169-25-000191.md) | [1.6 d](/filings/0000104169-26-000055.md) | [1.7](/filings/0000104169-26-000102.md) | [1.5](/filings/0000104169-26-000154.md) |
| Net income | $bn | [0.5](/filings/0000104169-24-000178.md) | [5.5 d](/filings/0000104169-26-000055.md) | [5.1](/filings/0000104169-25-000090.md) | [4.5](/filings/0000104169-25-000137.md) | [4.6](/filings/0000104169-25-000191.md) | [5.3 d](/filings/0000104169-26-000055.md) | [4.5](/filings/0000104169-26-000102.md) | [7.0](/filings/0000104169-26-000154.md) | [6.1](/filings/0000104169-25-000191.md) | [4.2 d](/filings/0000104169-26-000055.md) | [5.3](/filings/0000104169-26-000102.md) | [6.4](/filings/0000104169-26-000154.md) |
| Diluted EPS | $ per share | [0.06](/filings/0000104169-24-000178.md) | not reported | [0.63](/filings/0000104169-25-000090.md) | [0.56](/filings/0000104169-25-000137.md) | [0.57](/filings/0000104169-25-000191.md) | not reported | [0.56](/filings/0000104169-26-000102.md) | [0.88](/filings/0000104169-26-000154.md) | [0.77](/filings/0000104169-25-000191.md) | not reported | [0.67](/filings/0000104169-26-000102.md) | [0.80](/filings/0000104169-26-000154.md) |
| Basic EPS | $ per share | [0.06](/filings/0000104169-24-000178.md) | not reported | [0.63](/filings/0000104169-25-000090.md) | [0.56](/filings/0000104169-25-000137.md) | [0.57](/filings/0000104169-25-000191.md) | not reported | [0.56](/filings/0000104169-26-000102.md) | [0.88](/filings/0000104169-26-000154.md) | [0.77](/filings/0000104169-25-000191.md) | not reported | [0.67](/filings/0000104169-26-000102.md) | [0.80](/filings/0000104169-26-000154.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [12.2](/filings/0000104169-24-000178.md) | [9.9](/filings/0000104169-25-000021.md) | [9.4](/filings/0000104169-25-000090.md) | [8.8](/filings/0000104169-25-000137.md) | [10.0](/filings/0000104169-25-000191.md) | [9.0](/filings/0000104169-26-000055.md) | [9.3](/filings/0000104169-26-000102.md) | [9.4](/filings/0000104169-26-000154.md) | [10.6](/filings/0000104169-25-000191.md) | [10.7](/filings/0000104169-26-000154.md) | [10.7](/filings/0000104169-26-000102.md) | [11.5](/filings/0000104169-26-000154.md) |
| Current assets | $bn | [88.4](/filings/0000104169-24-000178.md) | [76.9](/filings/0000104169-25-000021.md) | [77.2](/filings/0000104169-25-000090.md) | [76.5](/filings/0000104169-25-000137.md) | [86.9](/filings/0000104169-25-000191.md) | [79.5](/filings/0000104169-26-000055.md) | [80.3](/filings/0000104169-26-000102.md) | [82.0](/filings/0000104169-26-000154.md) | [92.9](/filings/0000104169-25-000191.md) | [84.9](/filings/0000104169-26-000154.md) | [88.4](/filings/0000104169-26-000102.md) | [88.7](/filings/0000104169-26-000154.md) |
| Total assets | $bn | [259](/filings/0000104169-24-000178.md) | [252](/filings/0000104169-26-000055.md) | [254](/filings/0000104169-25-000090.md) | [254](/filings/0000104169-25-000137.md) | [263](/filings/0000104169-25-000191.md) | [261](/filings/0000104169-26-000055.md) | [262](/filings/0000104169-26-000102.md) | [271](/filings/0000104169-26-000154.md) | [289](/filings/0000104169-25-000191.md) | [285](/filings/0000104169-26-000154.md) | [290](/filings/0000104169-26-000102.md) | [294](/filings/0000104169-26-000154.md) |
| Current liabilities | $bn | [104](/filings/0000104169-24-000178.md) | [92.4](/filings/0000104169-25-000021.md) | [96.1](/filings/0000104169-25-000090.md) | [95.3](/filings/0000104169-25-000137.md) | [103](/filings/0000104169-25-000191.md) | [96.6](/filings/0000104169-26-000055.md) | [103](/filings/0000104169-26-000102.md) | [104](/filings/0000104169-26-000154.md) | [116](/filings/0000104169-25-000191.md) | [107](/filings/0000104169-26-000154.md) | [115](/filings/0000104169-26-000102.md) | [116](/filings/0000104169-26-000154.md) |
| Long-term debt | $bn | [36.3](/filings/0000104169-24-000178.md) | [36.1](/filings/0000104169-25-000021.md) | [35.9](/filings/0000104169-25-000090.md) | [35.4](/filings/0000104169-25-000137.md) | [33.6](/filings/0000104169-25-000191.md) | [33.4](/filings/0000104169-26-000055.md) | [36.5](/filings/0000104169-26-000102.md) | [35.6](/filings/0000104169-26-000154.md) | [34.4](/filings/0000104169-25-000191.md) | [34.6](/filings/0000104169-26-000154.md) | [36.9](/filings/0000104169-26-000102.md) | [36.5](/filings/0000104169-26-000154.md) |
| Current portion of debt | $bn | [2.8](/filings/0000104169-24-000178.md) | [3.4](/filings/0000104169-25-000021.md) | [1.9](/filings/0000104169-25-000090.md) | [1.5](/filings/0000104169-25-000137.md) | [3.2](/filings/0000104169-25-000191.md) | [2.6](/filings/0000104169-26-000055.md) | [4.1](/filings/0000104169-26-000102.md) | [4.0](/filings/0000104169-26-000154.md) | [3.5](/filings/0000104169-25-000191.md) | [3.5](/filings/0000104169-26-000154.md) | [3.9](/filings/0000104169-26-000102.md) | [3.5](/filings/0000104169-26-000154.md) |
| Short-term borrowings | $bn | [9.9](/filings/0000104169-24-000178.md) | [0.9](/filings/0000104169-25-000021.md) | [5.5](/filings/0000104169-25-000090.md) | [3.2](/filings/0000104169-25-000137.md) | [3.6](/filings/0000104169-25-000191.md) | [3.1](/filings/0000104169-26-000055.md) | [5.6](/filings/0000104169-26-000102.md) | [3.8](/filings/0000104169-26-000154.md) | [8.4](/filings/0000104169-25-000191.md) | [6.6](/filings/0000104169-26-000154.md) | [10.7](/filings/0000104169-26-000102.md) | [10.5](/filings/0000104169-26-000154.md) |
| Shareholders' equity | $bn | [79.5](/filings/0000104169-24-000178.md) | [83.9](/filings/0000104169-25-000021.md) | [81.3](/filings/0000104169-25-000090.md) | [84.4](/filings/0000104169-25-000137.md) | [88.1](/filings/0000104169-25-000191.md) | [91.0](/filings/0000104169-26-000055.md) | [83.8](/filings/0000104169-26-000102.md) | [90.1](/filings/0000104169-26-000154.md) | [96.1](/filings/0000104169-25-000191.md) | [99.6](/filings/0000104169-26-000154.md) | [94.3](/filings/0000104169-26-000102.md) | [98.2](/filings/0000104169-26-000154.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [0.8 d](/filings/0000104169-24-000178.md) | [16.7 d](/filings/0000104169-26-000055.md) | [4.2](/filings/0000104169-25-000090.md) | [12.1 d](/filings/0000104169-25-000137.md) | [6.6 d](/filings/0000104169-25-000191.md) | [13.5 d](/filings/0000104169-26-000055.md) | [5.4](/filings/0000104169-26-000102.md) | [12.9 d](/filings/0000104169-26-000154.md) | [9.1 d](/filings/0000104169-25-000191.md) | [14.1 d](/filings/0000104169-26-000055.md) | [4.7](/filings/0000104169-26-000102.md) | [15.0 d](/filings/0000104169-26-000154.md) |
| Capital expenditure | $bn | [5.5 d](/filings/0000104169-24-000178.md) | [5.9 d](/filings/0000104169-26-000055.md) | [4.7](/filings/0000104169-25-000090.md) | [5.8 d](/filings/0000104169-25-000137.md) | [6.2 d](/filings/0000104169-25-000191.md) | [7.1 d](/filings/0000104169-26-000055.md) | [5.0](/filings/0000104169-26-000102.md) | [6.4 d](/filings/0000104169-26-000154.md) | [7.2 d](/filings/0000104169-25-000191.md) | [8.0 d](/filings/0000104169-26-000055.md) | [6.7](/filings/0000104169-26-000102.md) | [7.5 d](/filings/0000104169-26-000154.md) |
| Dividends paid | $bn | [1.5 d](/filings/0000104169-24-000178.md) | [1.5 d](/filings/0000104169-26-000055.md) | [1.7](/filings/0000104169-25-000090.md) | [1.7 d](/filings/0000104169-25-000137.md) | [1.7 d](/filings/0000104169-25-000191.md) | [1.7 d](/filings/0000104169-26-000055.md) | [1.9](/filings/0000104169-26-000102.md) | [1.9 d](/filings/0000104169-26-000154.md) | [1.9 d](/filings/0000104169-25-000191.md) | [1.9 d](/filings/0000104169-26-000055.md) | [2.0](/filings/0000104169-26-000102.md) | [2.0 d](/filings/0000104169-26-000154.md) |
| Share repurchases | $bn | [0.1 d](/filings/0000104169-24-000178.md) | [1.5 d](/filings/0000104169-26-000055.md) | [1.1](/filings/0000104169-25-000090.md) | [1.0 d](/filings/0000104169-25-000137.md) | [1.0 d](/filings/0000104169-25-000191.md) | [1.4 d](/filings/0000104169-26-000055.md) | [4.6](/filings/0000104169-26-000102.md) | [1.6 d](/filings/0000104169-26-000154.md) | [0.8 d](/filings/0000104169-25-000191.md) | [1.1 d](/filings/0000104169-26-000055.md) | [2.1](/filings/0000104169-26-000102.md) | [3.0 d](/filings/0000104169-26-000154.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,711](/filings/0000104169-23-000132.md) | [8,112](/filings/0000104169-24-000105.md) | [8,108](/filings/0000104169-24-000141.md) | [8,110](/filings/0000104169-24-000178.md) | [8,084](/filings/0000104169-25-000090.md) | [8,081](/filings/0000104169-25-000137.md) | [8,082](/filings/0000104169-25-000191.md) | [8,051](/filings/0000104169-26-000102.md) | [8,016](/filings/0000104169-26-000154.md) | [8,011](/filings/0000104169-25-000191.md) | [7,999](/filings/0000104169-26-000102.md) | [7,978](/filings/0000104169-26-000154.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,933,746,241 at 2026-08-26, from the cover of the [10-Q filed 2026-08-28](/filings/0000104169-26-000154.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.
